Anita Gothelf

7PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 22, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.

Sebastian Søby, Robin Prestwich, Niels Gyldenkerne

|Aug 10, 2023
A systematic review on clinical adaptive radiotherapy for head and neck cancer.

Anne Marie Lindegaard, Katrin Håkansson, Mogens Bernsdorf

|Aug 07, 2023
The potential for local ablative therapy of oligometastases in head and neck squamous cell carcinoma: a real-world data analysis.

Julie Kjems, Michael R T Laursen, Claus A Kristensen

|Aug 01, 2022
Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study.

Sebastian Søby, Anita Gothelf, Niels Gyldenkerne

|Dec 19, 2020
3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas.

Charlotte A Espensen, Jens F Kiilgaard, Kristian Klemp

|May 16, 2020
Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas.

Charlotte A Espensen, Ane L Appelt, Lotte S Fog

Pageof 2